BIO Asia–Taiwan

BIO Asia–Taiwan

生物技術研究

Get Involved in Asia's largest biotech networking event!

關於我們

Jointly organized by both the global Biotechnology Innovation Organization (BIO) and the Taiwan Bio Industry Organization (Taiwan BIO) the BIO Asia–Taiwan International Conference and Exhibition was held for the first time in 2019. The gathering was a roaring success and exceeded all expectations, with more than 1,500 from 25 countries representing biomedical, pharmaceutical, genomics, biotech services, equipment and instruments, academic research, cosmetology products and bio-based healthcare attending the five-day festival of events.

產業
生物技術研究
公司規模
51-200 名員工
總部
taipei city
類型
非營利組織
專長
Biotechnology、pharmaceutical、Regenerative medicine、cell therapy、business development、precision medicine、venture capital、artificial intelligent、innovation、biologics、microbiome、medtech、digital health、therapeutics、life sciences、investment和CDMO

地點

  • 主要

    Room 229, Bldg. C, No.99, Ln. 130, Sec. 1, Academia Rd.

    115 TWtaipei city

    查詢路線

BIO Asia–Taiwan員工

動態消息

  • 瀏覽BIO Asia–Taiwan的組織專頁,圖案

    1,803 位關注者

    Once more, congratulations to all 2024 Taiwan BIO Award winners!

    <TBIO Activity> Vice President Hsiao met with the "2024 Taiwan BIO Award" winners on Oct. 15, acknowledging their dedication to the industry and their achievements across various fields. She emphasized that the government has continued to support the biotechnology sector through various policies in recent years, aiming to see the industry play a more critical role both in Taiwan and globally. She expressed hope for continued efforts to drive the industry's growth, making it a significant force in promoting public health. During her speech, the Vice President said she was honored to welcome the outstanding biotech companies and the representatives. She also thanked the "Taiwan Bio Industry Organization" for inviting her to attend this year's "BIO Asia–Taiwan" exhibition in July, which was an eye-opening experience. The Vice President highlighted the importance of the biotechnology industry to Taiwan, stating that through meetings and exchanges with industry professionals and scholars, as well as attending industry-related events, she has observed Taiwan's continuous progress and development in the biotech sector. Over the past few years, the government has consistently supported the industry through various policies, hoping that the biotech industry can play a more critical role both in Taiwan and on the global stage. She pointed out that due to the pandemic, there were disruptions in the global supply chain, and the world was competing for essential medical supplies. This situation underscored the complexity of global supply chains and reminded us that a strong local biotechnology industry is crucial, whether in meeting the expectations of the people or fulfilling the government's responsibility for public health. In conclusion, the Vice President congratulated all award winners for their contributions and cross-disciplinary achievements in the biotech industry, including areas such as medical devices, pharmaceuticals, research and development, agriculture, and health foods. She expressed hope for continued efforts to drive the industry's development, making it a key force in promoting public health. News Release (in Chinese): https://lnkd.in/gBCg3nZj The 2024 Taiwan BIO Award Winners: Bonraybio Corporation Lotus Pharmaceutical Co., Ltd PharmaEssentia Pharmosa Biopharm Inc TSH Biopharm Corporation Ltd Steminent Biotherapeutics Onyx Healthcare 明基透析科技 (BenQ Dialysis Technology Corp.) Acepodia ImmunAdd Inc. Sunhawk Vision Biotech (視航生物) Elixiron Immunotherapeutics BioGend Therapeutics (TWSE 6733) BRAXX Biotech Co., Ltd. Protect Animal Health Inc. Formosa Pharmaceuticals, Inc. TaiGen Biotechnology (太景生物) HippoScreen Neurotech Corp. Syngen Biotech

    • 無圖片說明
    • 無圖片說明
    • 無圖片說明
    • 無圖片說明
  • 瀏覽BIO Asia–Taiwan的組織專頁,圖案

    1,803 位關注者

    Please come say hi at <Booth B-56>, the Taiwan Pavilion, if you're also in #BioJapan2024, or look us up in the partnering system for a chat to learn more about BIO Asia-Taiwan 2025!

    瀏覽Taiwan Bio Industry Organization (Taiwan BIO)的組織專頁,圖案

    598 位關注者

    <TBIO Activity> TBIO will join the upcoming #BioJapan2024 (by BioJapan / JTB Communication Design) with Biotechnology and Pharmaceutical Industries Promotion Office (#BPIPO) and the following companies at the Taiwan Pavilion (➡️Booth No. B-56): Amaran Biotechnology, Inc. 向榮生技UnicoCell Biomed FEBICO遠東生技 #TaiGenBiotechnology (太景生物科技股份有限公司) LumiSTAR Biotechnology, Inc. 昱星生物科技 Bora Pharmaceuticals (Bora Biologics) King's Ground Biotech Level Biotechnology Inc. (3118) 生技中心 (Development Center for Biotechnology) PELL Bio-Med Technology (沛爾生醫)  KriSan Biotech Co., Ltd. Steminent Biotherapeutics ACRO Biomedical Co., Ltd. Look up for more Taiwanese companies as Exhibitors and in Partnering: https://lnkd.in/g9wg647u.. Taiwan Pavilion Activities: 👉 Thursday Oct. 10 at 10:15-11:30 Main Stage Seminar - Biocluster Summit "Taiwan's Key Role in Building Successful Asian Biotech Ventures" by Dr. Michael Huang, Acting Director, BPIPO 👉 Thursday Oct. 10 at 16:00-17:00 HAPPY HOUR at the Taiwan Pavilion Please feel free to stop by at booth ⭐B-56⭐ to say hi, or schedule a partnering meeting with us!

    • 無圖片說明
    • 無圖片說明
    • 無圖片說明
    • 無圖片說明
  • 瀏覽BIO Asia–Taiwan的組織專頁,圖案

    1,803 位關注者

    As one of BIO Asia-Taiwan's long term sponsor and partner, 台康生技股份有限公司 (EirGenix) also held an exclusive exhibition and interactive session at BIO Asia-Taiwan in July this year showcasing its strong capabilities and global reach. Read the interview by BioSpectrum Asia with EirGenix during BIO Asia-Taiwan to discussed the company's global growth strategies and recent ventures more extensively: https://lnkd.in/g8DNtTTB

    EirGenix's comprehensive CDMO services strengthening Taiwan’s position in the global biopharmaceutical landscape

    EirGenix's comprehensive CDMO services strengthening Taiwan’s position in the global biopharmaceutical landscape

    biospectrumasia.com

  • 瀏覽BIO Asia–Taiwan的組織專頁,圖案

    1,803 位關注者

    As one of BIO Asia-Taiwan's long term sponsor and partner, Bora Pharmaceuticals held an exclusive exhibition and interactive session again at BIO Asia-Taiwan in July this year, showcasing its strong growing capabilities and global growth strategies. Read the interview by BioSpectrum Asia with Bora Pharmaceuticals during BIO Asia-Taiwan: https://lnkd.in/g9B3c3xX

    Bora Pharmaceuticals with CDMO operations facilities in North America and Asia strives to advance Taiwan's biopharmaceutical excellence

    Bora Pharmaceuticals with CDMO operations facilities in North America and Asia strives to advance Taiwan's biopharmaceutical excellence

    biospectrumasia.com

  • 瀏覽BIO Asia–Taiwan的組織專頁,圖案

    1,803 位關注者

    Conference Highlights 🏆 BIO Asia Awards 2024 🏆 The BIO Asia Awards aims to recognize organizations and individuals that have made an outstanding contribution and impact in biotechnology over the previous year. This award, held for the first time in 2024, seeks to honor Asian industry leaders that have not only made the greatest technological advancements in their field but who also have contributed most to human welfare and progress through biotechnology. Nominees are chosen by the international committee members of BIO Asia–Taiwan (Individual, companies, or organization). All nominations will undergo thorough evaluation and submitted to the international committee judging panel for review. And the winners are: ✨ Organization Award: ✨ Takeda Pharmaceutical Company Limited Award accepted by Masanori Sato, Head of Japan/APAC Center for External Innovation, Takeda Pharmaceutical Company Limited "To recognize and honor the outstanding international contributions in biotechnology and healthcare space over the past years, including the researches and developments of innovative products, as well as the establishment of its Shonan Research Center to Shonan Health lnnovation Park (iPark), an incubation facility to enhance science and innovation bringing together startup companies, academia and other industry to create high-impact healthcare solutions from cutting-edge science in Asia.” ✨Individual Award:✨ George Hara, Group Chairman and CEO, DEFTA Partners Award accepted by Abby Yuanwei Gao, Depute Head & Director of Investment Research, DEFTA Partners (Hong Kong) "To recognize and honor the outstanding international contributions in biotechnology and healthcare space over the past years, including the contributions on international collaboration during his tenures for the Intergovernmental Ambassador Extraordinary and Plenipotentiary to United Nations and the advisor of to several ministries of Japanese Government on Economy, Trade and Industry. His contributions as the Chairman of the Alliance Forum Foundation and the Serving on the International Advisory Council of SALK Institute are highly recognized.”

    • 無圖片說明
    • 無圖片說明
    • 無圖片說明
    • 無圖片說明
  • 瀏覽BIO Asia–Taiwan的組織專頁,圖案

    1,803 位關注者

    Conference Highlights 🤝 Regional Collaboration Forum 🤝 For the very first time, the Taiwan BIO collaborated with the Taiwan External Trade Development Council (TAITRA) to co-host the Regional Collaboration Forum, which Australia, Japan, Belgium, Thailand, India, and Malaysia also each host their own country-specific forum with a total of 40 companies participating to explore cross nation collaboration opportunities. During the Plenary Session, representatives from each country shared insights on their respective industries. Helen Dai, Trade and Investment Commissioner, Australia Trade and Investment Commission (Austrade), highlighted Australia's strengths in clinical trials, including the government's efficient approval process and favorable policies for talent and immigration, making Australia a top destination for clinical trials. Els Verhulst, Science & Technology Counselor, FLANDERS INVESTMENT & TRADE, Embassy of Belgium in Tokyo, Japan, noted that Belgium is a major powerhouse in life sciences and pharmaceuticals, with the highest per capita investment in medical R&D in Europe, making it one of the world's top three "Medicine Valleys." Yoshiaki Tsukamoto, Executive Director, Japan Bioindustry Association (JBA), stated that Japan has globally leading capabilities in biotech and biopharmaceutical research. In recent years, Japan's biotech industry has placed a strong emphasis on innovation, especially in areas such as bio-pharmaceuticals, regenerative medicine, and gene editing. From Thailand, Nares Damrongchai, Co-Founder, Accel Group Co., Ltd. and former Director of the National TCELS Program, shared insights on the development of life sciences and diagnostic testing in Thailand, along with the nation's experience in international cooperation through the Asia-Pacific Economic Cooperation (APEC). Murali Panchapagesa Muthuswamy, former chairman of the Indian Biotech Industry Association, proposed collaborations between Taiwan's R&D and India's manufacturing capabilities, encouraging the use of India's production capacities for pharmaceuticals and vaccines. Representatives from all participating countries expressed a strong desire for increased cooperation in regulatory review across Asia, which would help biotech and pharmaceutical companies unlock international market opportunities. This collaboration aims to expand the scope of each country's biotech industry, fostering win-win and even multi-win situations, injecting new vitality into industry development and creating new opportunities across borders. Full Photo Albums: Plenary Session: https://lnkd.in/gUy_2mRh Belgium Session: https://lnkd.in/gxr3MU_S Japan Session: https://lnkd.in/gjECKmyC Thailand Session: https://lnkd.in/gep5Cgey India Session: https://lnkd.in/g4S5j4ys Malaysia Session: https://lnkd.in/gX56yzGi

    • 無圖片說明
    • 無圖片說明
    • 無圖片說明
    • 無圖片說明
    • 無圖片說明
      +1
  • 瀏覽BIO Asia–Taiwan的組織專頁,圖案

    1,803 位關注者

    Conference Highlights 🔥 Investment Summit🔥 This year's new track - Investment Summit - through venture capitals' selections, invited a total of 48 domestic and international outstanding biotech companies to present, including new drug development, digital therapeutics, AI applications in clinical trials, drug development, and imaging, reflecting venture capitalists' optimism about their future potential. The involvement of international venture capital firms has also seen a significant rise. Over 50 international investment institutions attended the event. Notable foreign participants included Flagship Pioneering and Illumina Ventures, UK-based Syncona, Prime Ventures, Vivo Capital, Israel's largest pharma venture fund aMoon, Pegasus Tech Ventures, Japan's DCI Partners, Axil Capital Partners, and more. 👉 Full Photo Album: https://lnkd.in/g2bSHTfx The speakers included: ✨Jorge Cortell, Senior Advisor Health & Life Sciences, Harvard University Innovation Laboratories ✨Jenny Yang, Head of External Innovation Asia Pacific, Novo Nordisk A/S ✨Jo Shen, Ph.D., Venture Partner, Vivo Capital ✨Alice Chen, PhD, Executive VP, Accelerator Life Science Partner ✨Gaurav Aggarwal, MD, Managing Partner, Vivo Capital ✨Gur Roshwalb, MD/PhD, Partner, aMoon Fund ✨John Tsai, MD, Executive Partner, Syncona ✨Yenchen Huang, VP, Diamond Biofund ✨Stephanie Marrus, Managing Director, Entrepreneurship, University of California San Francisco The pitching companies in MedTech & Digital Health were: 🎯aetherAI 雲象科技 🎯AIxMed, Inc. 🎯ANEUVO 🎯APrevent Biotech GmbH 🎯BioAro Inc. 🎯Bonraybio Corporation 🎯Brain Navi Biotechnology Co., Ltd. 🎯FaceHeart 🎯Flat Medical, Inc. 🎯Genialis 🎯HCmed Innovations Co., Ltd. 🎯JelloX Biotech Inc. 🎯oxipit The pitching companies in Therapeutics & Pharmaceuticals were: ⭐AcadeMab Biomedical ⭐ACCELERATED BIOSCIENCES CORP.AcepodiaAiViva Biopharma, Inc.Elixiron ImmunotherapeuticsAllgenesis Biotherapeutics Inc.AmMax Bio., Inc.安宏生醫AnnJi Pharmaceutical Co., Ltd.AP Biosciences ⭐Apexcella Biomedical ⭐Apeximmune TherapeuticsCellusion Inc.Cyto-Facto Inc.DotBio ⭐GEXVal ⭐HanchorBio Inc. 漢康生技股份有限公司Help TherapeuticsImmunworkLBL Biotech順天醫藥生技股份有限公司浩鼎生技股份有限公司Ochre BioOnward Therapeutics ⭐REGiMMUNE ⭐Rock BioMedical ⭐TFBS Bioscience, Inc. ⭐TMS ⭐TriArm TherapeuticsTWi Biotechnology 安成生物科技股份有限公司United Immunity, Co., Ltd. ⭐Xgene Pharmaceutical ⭐XWPharma

    • 無圖片說明
    • 無圖片說明
    • 無圖片說明
    • 無圖片說明
    • 無圖片說明
      +13
  • 瀏覽BIO Asia–Taiwan的組織專頁,圖案

    1,803 位關注者

    Conference Highlights Session 13 – Shaping the Future of Digital Health Held over lunch, Session 13 opened with talks by Chien-Cheng Tai, Senior Technical Specialist, Department of Industrial Technology, Ministry of Economic Affairs; and Eric Y. Chuang, Director of the Biomedical Technology and Device Research Laboratories (BDL), ITRI. Nipun Jain, Director of AstraZeneca's Innovation and Partnerships, International Region, introduced the establishment of AstraZeneca's A.Catalyst Network, which is dedicated to promoting innovative therapies in Asia, East Asia, Africa, and Latin America. Tony Lee, Head of Sales, Google Cloud Taiwan, discussed various applications of Google AI in the healthcare field. In the subsequent discussion, moderated by Chuang, the two speakers, along with Jing-Wei Lee, Superintendent, National Cheng Kung University Hospital; Kai-Cheng Hsu, Chief Medical Officer, Biomedical Big Data & Artificial Intelligence Technology, BDL, ITRI; and Peter Kurz, Chief Strategy Officer, QIC, explored strategies for promoting precision medicine through policies and public-private partnerships. #StayTunedForMorePhotosAndHighlights #BIOAsiaTaiwan2024

    • 無圖片說明
    • 無圖片說明
    • 無圖片說明
    • 無圖片說明
    • 無圖片說明
      +8

相似頁面